| Biogen Switzerland AG - Spinraza 12mg/5ml, Injektionslösung zur intrathekalen Injektion |
| 66495 | | 01 | | Spinraza 12mg/5ml | | Injektionslösung zur intrathekalen Injektion | | M09AX | | Other Drugs for Disorders Of The Musculo-Skeletal System | | 20.09.2017 | | |
|
| Composition |
| nusinersenum 12 mg ut nusinersenum natricum 12.6 mg, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 18.17 mg et kalium 0.59 mg. |
| Packungsbestandteile |
| Injektionslösung zur intrathekalen Injektion | | | | | | | | Active Agent | Dose |
|---|
| Nusinersenum | 12mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Nusinersenum | 12 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum ad Ph | | Calcii Chloridum Dihydricum | | Disodium Phosphate | | Kalii Chloridum | | Magnesium Chloride Hexahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Natrii Hydroxidum ad Ph |
| |
|
|
